Pharmaceuticals, advancing Intercept’s medical and scientific program aligned with corporate goals and objectives. The MSL...POSITION SUMMARY: As Intercept continues to build its position as the leader in rare and serious liver disease...
Pharmaceuticals, advancing Intercept’s medical and scientific program aligned with corporate goals and objectives. The MSL...POSITION SUMMARY: As Intercept continues to build its position as the leader in rare and serious liver disease...
relationships with a variety of stakeholders within this segment Establish InterceptPharmaceuticals as a strategic partner...POSITION SUMMARY: As Intercept continues to build its position as the leader in rare and serious liver disease...
POSITION SUMMARY: As Intercept continues to build its position as the leader in rare and serious liver disease..., commercial, and market access teams to integrate MSL activities into Intercept business objectives Contribute to strategic...
POSITION SUMMARY: As Intercept continues to build its position as the leader in rare and serious liver disease... for integrating and effectively communicating scientific/medical information and value proposition of Intercept's product and pipeline...
POSITION SUMMARY: As Intercept continues to build its position as the leader in rare and serious liver disease... that will provide access and therapy management services for Intercept’s products to patients. The DCA will report directly into the...
POSITION SUMMARY: As Intercept continues to build its position as the leader in rare and serious liver disease... strategy and governance of all commercial data assets, the management of Intercept’s commercial data environment as well...
POSITION SUMMARY: As Intercept continues to build its position as the leader in rare and serious liver disease... skills Learning agility and ‘scalability’ to take on increasing responsibility as Intercept grows Consistent demonstration...